Ohughi and colleagues were able to show that KDM3A overexpression interferes with MM cells homing in the bone marrow and survival via the demethylation of H3K9 and subsequent activation of KLF2 and IRF4 [92]. This evidence concerns the gene KDM3A and Miyoshi myopathy.